A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Clinical trial NCT00617461 · COMPLETED

Trial details

NCT number: NCT00617461
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuralgia, Postherpetic

Start date: 2008-03-01
Primary completion: 2009-07-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.